Literature DB >> 33414986

Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.

Yongting Lai1, Hairong Huang2, Mubalake Abudoureyimu3, Xinrong Lin3, Chuan Tian3, Ting Wang3, Xiaoyuan Chu1,3, Rui Wang1,3.   

Abstract

Reprogramming of metabolism is one of the hallmarks of cancer, among which glucose metabolism dysfunction is the most prominent feature. The glucose metabolism of tumor cells is significantly different from that of normal cells. Glucose metabolism reprogramming of hepatocellular carcinoma (HCC) has become an important research hotspot in the field of HCC, a variety of tumor metabolic interventions have been applied clinically. Moreover, various Non-coding RNAs (ncRNAs) including microRNAs (miRNAs), long non-coding (lncRNAs) as well as circular RNAs (circRNAs), have recently been proved to play potential roles in glucose metabolism. This review summarizes the effects of ncRNAs on HCC that participate in glucose metabolism and discuss the related mechanisms to find potential and effective targeted treatments for HCC. AJCR
Copyright © 2020.

Entities:  

Keywords:  Hepatocellular carcinoma; circular RNAs; glucose metabolism; glycolysis; long non-coding RNAs; microRNAs; non-coding RNA

Year:  2020        PMID: 33414986      PMCID: PMC7783776     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  119 in total

Review 1.  MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship.

Authors:  Amy E Pasquinelli
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

Review 2.  Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.

Authors:  S J Pilkis; D K Granner
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

3.  RNA-based therapeutics: ready for delivery?

Authors:  Laura Bonetta
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

4.  The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.

Authors:  Hui Shi; Runping Fang; Yinghui Li; Leilei Li; Weiying Zhang; Huawei Wang; Fuquan Chen; Shuqin Zhang; Xiaodong Zhang; Lihong Ye
Journal:  Cancer Lett       Date:  2016-09-05       Impact factor: 8.679

5.  In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter.

Authors:  Chih-Hsiung Wu; Yuan-Soon Ho; Chia-Yi Tsai; Ying-Jan Wang; How Tseng; Po-Li Wei; Chia-Hwa Lee; Ren-Shyan Liu; Shyr-Yi Lin
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

6.  Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.

Authors:  Ling-Fei Zhang; Jia-Tao Lou; Ming-Hua Lu; Chunfang Gao; Shuang Zhao; Biao Li; Sheng Liang; Yong Li; Dangsheng Li; Mo-Fang Liu
Journal:  EMBO J       Date:  2015-09-07       Impact factor: 11.598

Review 7.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

8.  The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer.

Authors:  Zhixiong Fang; Langqiu He; Hui Jia; Qiusheng Huang; Dan Chen; Zhiwei Zhang
Journal:  Iran J Basic Med Sci       Date:  2017-02       Impact factor: 2.699

9.  LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect.

Authors:  Shaoxun Xiang; Hao Gu; Lei Jin; Rick F Thorne; Xu Dong Zhang; Mian Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

10.  HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p.

Authors:  Yufan Zhou; Yun Huang; Kuan Hu; Zeyu Zhang; Jiajin Yang; Zhiming Wang
Journal:  Cell Death Dis       Date:  2020-03-09       Impact factor: 8.469

View more
  3 in total

1.  Analysis of the expression, function and signaling of glycogen phosphorylase isoforms in hepatocellular carcinoma.

Authors:  Lingyu Jiang; Shuyan Liu; Tingzhi Deng; Yang Yang; Yin Zhang
Journal:  Oncol Lett       Date:  2022-06-07       Impact factor: 3.111

Review 2.  Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer.

Authors:  Ying Yang; Wen-Jian Meng; Zi-Qiang Wang
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

3.  Inhibition of PIKfyve Ameliorates the Proliferation and Migration of Vascular Smooth Muscle Cells and Vascular Intima Hyperplasia By Reducing mTORC1 Activity.

Authors:  Min Gu; Zhen Wang; Feifei Feng; Yongjian Yang; Xiongshan Sun; Dachun Yang
Journal:  J Cardiovasc Pharmacol       Date:  2022-05-01       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.